You are here: Home » Research Articles » What is Melanotan-II?

What is Melanotan-II?

	By Cocer Peptides By Cocer Peptides June 4, 2025 June 4, 2025

Melanotan-II (MT-II) is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (alpha-MSH) belonging to the class of melanocortin receptor agonists. Originally synthesized at the University of Arizona during research into peptide-driven melanogenesis, MT-II is a non-selective agonist that binds with high affinity to several melanocortin receptor subtypes, including MC1R, MC3R, MC4R, and MC5R. Structurally, the peptide contains a lactam bridge that confers increased enzymatic stability compared to endogenous linear melanocortin peptides, making it a valuable tool in preclinical studies examining receptor activation pathways.

In laboratory and preclinical settings, researchers evaluate MT-II to map its interactions with central and peripheral melanocortin pathways. In skin tissue models, its interaction with MC1R on melanocytes activates adenylate cyclase, elevating intracellular cyclic AMP (cAMP) and initiating microphthalmia-associated transcription factor (MITF) phosphorylation. This cascade upregulates melanogenic enzymes, including tyrosinase, tyrosinase-related protein-1 (TRP-1), and tyrosinase-related protein-2 (TRP-2). Central nervous system studies observe that MT-II administration influences hypothalamic signaling, inducing Fos expression within the suprachiasmatic nucleus and paraventricular nucleus, modulating oxytocin neuronal firing rates, and interacting with mast cell-mediated histamine pathways and sympathetic thermogenic responses in brown adipose tissue.

In academic and clinical literature, MT-II is examined across diverse preclinical models, including maternal immune activation (MIA) behavioral assays, high-fat diet cognitive impairment models, energy homeostatic assays, and early-stage central pathway investigations related to erectile dysfunction. Regulatory authorities worldwide, including the US Food and Drug Administration (FDA), have not approved Melanotan-II for human use, tanning, or the treatment of any medical condition. Concerns regarding safety profiles, potential adverse events, and unverified commercial distribution keep MT-II classified strictly as an unapproved investigational research peptide reserved for laboratory experimentation.

Product available for research use only:

3

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE SOLELY FOR INFORMATION DISSEMINATION AND EDUCATIONAL PURPOSES.  

The products provided on this website are intended exclusively for in vitro research. In vitro research (Latin: *in glass*, meaning in glassware) is conducted outside the human body. These products are not pharmaceuticals, have not been approved by the U.S. Food and Drug Administration (FDA), and must not be used to prevent, treat, or cure any medical condition, disease, or ailment. It is strictly prohibited by law to introduce these products into the human or animal body in any form.

Contact Us Now for A Quote!